Calcium in PDB 2ddy: Solution Structure of Matrilysin (Mmp-7) Complexed to Constraint Conformational Sulfonamide Inhibitor
Enzymatic activity of Solution Structure of Matrilysin (Mmp-7) Complexed to Constraint Conformational Sulfonamide Inhibitor
All present enzymatic activity of Solution Structure of Matrilysin (Mmp-7) Complexed to Constraint Conformational Sulfonamide Inhibitor:
3.4.24.23;
Other elements in 2ddy:
The structure of Solution Structure of Matrilysin (Mmp-7) Complexed to Constraint Conformational Sulfonamide Inhibitor also contains other interesting chemical elements:
Calcium Binding Sites:
The binding sites of Calcium atom in the Solution Structure of Matrilysin (Mmp-7) Complexed to Constraint Conformational Sulfonamide Inhibitor
(pdb code 2ddy). This binding sites where shown within
5.0 Angstroms radius around Calcium atom.
In total 2 binding sites of Calcium where determined in the
Solution Structure of Matrilysin (Mmp-7) Complexed to Constraint Conformational Sulfonamide Inhibitor, PDB code: 2ddy:
Jump to Calcium binding site number:
1;
2;
Calcium binding site 1 out
of 2 in 2ddy
Go back to
Calcium Binding Sites List in 2ddy
Calcium binding site 1 out
of 2 in the Solution Structure of Matrilysin (Mmp-7) Complexed to Constraint Conformational Sulfonamide Inhibitor
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 1 of Solution Structure of Matrilysin (Mmp-7) Complexed to Constraint Conformational Sulfonamide Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca174
b:2.0
occ:1.00
|
OD2
|
A:ASP76
|
2.2
|
-0.7
|
1.0
|
O
|
A:GLY77
|
2.3
|
-0.6
|
1.0
|
O
|
A:GLY79
|
2.4
|
-0.6
|
1.0
|
O
|
A:THR81
|
2.4
|
-0.6
|
1.0
|
OE1
|
A:GLU102
|
2.5
|
-0.6
|
1.0
|
OD1
|
A:ASP76
|
2.8
|
-0.6
|
1.0
|
CG
|
A:ASP76
|
2.8
|
0.7
|
1.0
|
HD2
|
A:ASP76
|
3.1
|
0.5
|
1.0
|
OD1
|
A:ASP99
|
3.1
|
-0.6
|
1.0
|
H
|
A:GLY79
|
3.3
|
0.4
|
1.0
|
HA
|
A:LEU82
|
3.3
|
0.0
|
1.0
|
HG3
|
A:GLU102
|
3.4
|
0.0
|
1.0
|
C
|
A:GLY77
|
3.4
|
0.6
|
1.0
|
C
|
A:THR81
|
3.5
|
0.6
|
1.0
|
C
|
A:GLY79
|
3.5
|
0.6
|
1.0
|
CD
|
A:GLU102
|
3.5
|
0.7
|
1.0
|
H
|
A:GLY77
|
3.5
|
0.4
|
1.0
|
N
|
A:GLY79
|
3.6
|
-0.7
|
1.0
|
N
|
A:GLY77
|
3.8
|
-0.7
|
1.0
|
HG2
|
A:GLU102
|
3.8
|
0.0
|
1.0
|
CG
|
A:GLU102
|
3.8
|
0.1
|
1.0
|
HB3
|
A:ASN80
|
4.0
|
0.0
|
1.0
|
H
|
A:ASP76
|
4.0
|
0.4
|
1.0
|
HB3
|
A:ASP99
|
4.1
|
0.0
|
1.0
|
CG
|
A:ASP99
|
4.1
|
0.7
|
1.0
|
CA
|
A:GLY79
|
4.1
|
0.4
|
1.0
|
CA
|
A:GLY77
|
4.2
|
0.4
|
1.0
|
HA
|
A:PRO78
|
4.2
|
0.0
|
1.0
|
CA
|
A:LEU82
|
4.2
|
0.4
|
1.0
|
N
|
A:LEU82
|
4.2
|
-0.7
|
1.0
|
HG
|
A:LEU82
|
4.3
|
0.0
|
1.0
|
N
|
A:THR81
|
4.3
|
-0.7
|
1.0
|
HB2
|
A:ASP99
|
4.3
|
0.0
|
1.0
|
CB
|
A:ASP76
|
4.3
|
0.1
|
1.0
|
HD1
|
A:PHE75
|
4.3
|
0.1
|
1.0
|
C
|
A:PRO78
|
4.4
|
0.6
|
1.0
|
N
|
A:PRO78
|
4.4
|
-0.7
|
1.0
|
C
|
A:ASN80
|
4.4
|
0.6
|
1.0
|
CB
|
A:ASP99
|
4.5
|
0.1
|
1.0
|
CA
|
A:THR81
|
4.5
|
0.4
|
1.0
|
C
|
A:ASP76
|
4.5
|
0.6
|
1.0
|
HB
|
A:THR81
|
4.6
|
0.0
|
1.0
|
CA
|
A:PRO78
|
4.6
|
0.4
|
1.0
|
N
|
A:ASN80
|
4.6
|
-0.7
|
1.0
|
HA2
|
A:GLY77
|
4.6
|
0.0
|
1.0
|
N
|
A:ASP76
|
4.7
|
-0.7
|
1.0
|
OE2
|
A:GLU102
|
4.7
|
-0.7
|
1.0
|
HB2
|
A:ASP76
|
4.7
|
0.0
|
1.0
|
CA
|
A:ASP76
|
4.8
|
0.4
|
1.0
|
HA3
|
A:GLY79
|
4.8
|
0.0
|
1.0
|
HE2
|
A:GLU102
|
4.8
|
0.5
|
1.0
|
CA
|
A:ASN80
|
4.8
|
0.4
|
1.0
|
CB
|
A:ASN80
|
4.9
|
0.1
|
1.0
|
O
|
A:ASN80
|
4.9
|
-0.6
|
1.0
|
HA2
|
A:GLY79
|
4.9
|
0.0
|
1.0
|
HB3
|
A:ASP76
|
4.9
|
0.0
|
1.0
|
H
|
A:THR81
|
4.9
|
0.4
|
1.0
|
|
Calcium binding site 2 out
of 2 in 2ddy
Go back to
Calcium Binding Sites List in 2ddy
Calcium binding site 2 out
of 2 in the Solution Structure of Matrilysin (Mmp-7) Complexed to Constraint Conformational Sulfonamide Inhibitor
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 2 of Solution Structure of Matrilysin (Mmp-7) Complexed to Constraint Conformational Sulfonamide Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca175
b:2.0
occ:1.00
|
OD2
|
A:ASP95
|
2.2
|
-0.7
|
1.0
|
OD1
|
A:ASP95
|
2.3
|
-0.6
|
1.0
|
O
|
A:GLY91
|
2.4
|
-0.6
|
1.0
|
O
|
A:GLY93
|
2.4
|
-0.6
|
1.0
|
CG
|
A:ASP95
|
2.5
|
0.7
|
1.0
|
O
|
A:ASP59
|
2.5
|
-0.6
|
1.0
|
HA
|
A:ASP59
|
3.1
|
0.0
|
1.0
|
HD2
|
A:ASP95
|
3.2
|
0.5
|
1.0
|
C
|
A:ASP59
|
3.4
|
0.6
|
1.0
|
C
|
A:GLY93
|
3.5
|
0.6
|
1.0
|
C
|
A:GLY91
|
3.6
|
0.6
|
1.0
|
HH2
|
A:TRP10
|
3.6
|
0.1
|
1.0
|
O
|
A:ALA58
|
3.7
|
-0.6
|
1.0
|
H
|
A:MET61
|
3.7
|
0.4
|
1.0
|
O
|
A:LEU92
|
3.7
|
-0.6
|
1.0
|
C
|
A:LEU92
|
3.7
|
0.6
|
1.0
|
HA
|
A:LEU92
|
3.8
|
0.0
|
1.0
|
N
|
A:ASP95
|
3.8
|
-0.7
|
1.0
|
CA
|
A:ASP59
|
3.8
|
0.4
|
1.0
|
CB
|
A:ASP95
|
3.9
|
0.1
|
1.0
|
H
|
A:ASP95
|
4.0
|
0.4
|
1.0
|
N
|
A:GLY93
|
4.1
|
-0.7
|
1.0
|
CA
|
A:LEU92
|
4.1
|
0.4
|
1.0
|
HA3
|
A:GLY94
|
4.2
|
0.0
|
1.0
|
HB2
|
A:ASP95
|
4.2
|
0.0
|
1.0
|
HA
|
A:ILE60
|
4.2
|
0.0
|
1.0
|
CA
|
A:ASP95
|
4.3
|
0.4
|
1.0
|
HA
|
A:ASP95
|
4.3
|
0.0
|
1.0
|
N
|
A:LEU92
|
4.3
|
-0.7
|
1.0
|
N
|
A:ILE60
|
4.4
|
-0.7
|
1.0
|
C
|
A:GLY94
|
4.4
|
0.6
|
1.0
|
N
|
A:GLY94
|
4.4
|
-0.7
|
1.0
|
CA
|
A:GLY93
|
4.4
|
0.4
|
1.0
|
CA
|
A:GLY94
|
4.6
|
0.4
|
1.0
|
HB2
|
A:MET61
|
4.6
|
0.0
|
1.0
|
N
|
A:MET61
|
4.6
|
-0.7
|
1.0
|
C
|
A:ALA58
|
4.6
|
0.6
|
1.0
|
CH2
|
A:TRP10
|
4.6
|
-0.1
|
1.0
|
HG21
|
A:THR57
|
4.6
|
0.0
|
1.0
|
HB3
|
A:ASP95
|
4.6
|
0.0
|
1.0
|
H
|
A:GLY93
|
4.7
|
0.4
|
1.0
|
HB3
|
A:MET61
|
4.7
|
0.0
|
1.0
|
N
|
A:GLY91
|
4.7
|
-0.7
|
1.0
|
N
|
A:ASP59
|
4.7
|
-0.7
|
1.0
|
CA
|
A:GLY91
|
4.7
|
0.4
|
1.0
|
HB3
|
A:ASP59
|
4.8
|
0.0
|
1.0
|
CA
|
A:ILE60
|
4.8
|
0.4
|
1.0
|
CB
|
A:ASP59
|
4.9
|
0.1
|
1.0
|
HZ3
|
A:TRP10
|
5.0
|
0.1
|
1.0
|
HA3
|
A:GLY93
|
5.0
|
0.0
|
1.0
|
|
Reference:
X.H.Zheng,
L.Ou,
Q.Zhang,
H.Wu.
Solution Structure of Matrilysin (Mmp-7) Complexed to Constraint Conformational Sulfonamide Inhibitor To Be Published.
Page generated: Fri Jul 12 09:45:06 2024
|